Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Behre

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Leukemia|November 2, 2007
Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137LM Christopeit, M Schendel, J Föll, et al.
International Journal of Immunogenetics|July 14, 2007
A novel HLA-A*29 allele (A*2916) of a Caucasian relative to an ALL patient containing a point mutation in a putatively conserved region which was identified through the loss of a specific amplificate in a low-resolution SSP-PCR kitM Erhuma, C Radam, G Schlaf, et al.
Annals of Hematology|April 16, 1998
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patientsG Behre, H Link, G Maschmeyer, et al.
Bone Marrow Transplantation|February 22, 2007
Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipientsA Muetherig, M Christopeit, L P Müller, et al.
Annals of Hematology|August 20, 2002
Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropeniaM Goetz, G Behre, G Heussel, et al.
Bone Marrow Transplantation|December 3, 2013
Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinibN Jaekel, G Behre, A Behning, et al.
Cell Death & Disease|April 20, 2013
E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradationP Pal, S Lochab, J K Kanaujiya, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
New insights into the biology of acute myeloid leukemia and their impact on treatmentW Hiddemann, T Haferlach, C Schoch, et al.
Oncogene|May 30, 2006
Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modificationsM Y Balkhi, A K Trivedi, M Geletu, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2015
Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantationA Rockstroh, H K Al-Ali, T Lange, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Leukemia|November 2, 2007
Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137LM Christopeit, M Schendel, J Föll, et al.
International Journal of Immunogenetics|July 14, 2007
A novel HLA-A*29 allele (A*2916) of a Caucasian relative to an ALL patient containing a point mutation in a putatively conserved region which was identified through the loss of a specific amplificate in a low-resolution SSP-PCR kitM Erhuma, C Radam, G Schlaf, et al.
Annals of Hematology|April 16, 1998
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patientsG Behre, H Link, G Maschmeyer, et al.
Bone Marrow Transplantation|February 22, 2007
Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipientsA Muetherig, M Christopeit, L P Müller, et al.
Annals of Hematology|August 20, 2002
Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropeniaM Goetz, G Behre, G Heussel, et al.
Bone Marrow Transplantation|December 3, 2013
Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinibN Jaekel, G Behre, A Behning, et al.
Cell Death & Disease|April 20, 2013
E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradationP Pal, S Lochab, J K Kanaujiya, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
New insights into the biology of acute myeloid leukemia and their impact on treatmentW Hiddemann, T Haferlach, C Schoch, et al.
Oncogene|May 30, 2006
Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modificationsM Y Balkhi, A K Trivedi, M Geletu, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2015
Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantationA Rockstroh, H K Al-Ali, T Lange, et al.
Pageof 4